Fig. 7From: SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphomaCorrelation analysis between immune microenvironment and SLC27A2 in AML. In AML, there is a significant negative correlation between SLC27A2 and B cells, T cell CD8 + , and macrophagesBack to article page